Current status and future expectations of nanobodies in oncology trials.
Saved in:
| Title: | Current status and future expectations of nanobodies in oncology trials. |
|---|---|
| Authors: | De Pauw T; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., De Mey L; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium., Debacker JM; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium., Raes G; Cellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, Belgium.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium., Van Ginderachter JA; Cellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, Belgium.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium., De Groof TWM; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., Devoogdt N; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium. |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2023 Jul-Dec; Vol. 32 (8), pp. 705-721. Date of Electronic Publication: 2023 Aug 28. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37638538 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Current status and future expectations of nanobodies in oncology trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22De+Pauw+T%22">De Pauw T</searchLink>; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Mey+L%22">De Mey L</searchLink>; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Debacker+JM%22">Debacker JM</searchLink>; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Raes+G%22">Raes G</searchLink>; Cellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, Belgium.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+Ginderachter+JA%22">Van Ginderachter JA</searchLink>; Cellular and Molecular Immunology Lab, Vrije Universiteit Brussel, Brussels, Belgium.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Groof+TWM%22">De Groof TWM</searchLink>; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Devoogdt+N%22">Devoogdt N</searchLink>; In vivo Cellular and Molecular Imaging Laboratory, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229434197%22">Expert opinion on investigational drugs</searchLink> [Expert Opin Investig Drugs] 2023 Jul-Dec; Vol. 32 (8), pp. 705-721. <i>Date of Electronic Publication: </i>2023 Aug 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9434197 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213543784%22">13543784 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Investig Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37638538 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/13543784.2023.2249814 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 705 Titles: – TitleFull: Current status and future expectations of nanobodies in oncology trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: De Pauw T – PersonEntity: Name: NameFull: De Mey L – PersonEntity: Name: NameFull: Debacker JM – PersonEntity: Name: NameFull: Raes G – PersonEntity: Name: NameFull: Van Ginderachter JA – PersonEntity: Name: NameFull: De Groof TWM – PersonEntity: Name: NameFull: Devoogdt N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2023 Jul-Dec Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1744-7658 Numbering: – Type: volume Value: 32 – Type: issue Value: 8 Titles: – TitleFull: Expert opinion on investigational drugs Type: main |
| ResultId | 1 |
